Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Patent cliff"'
Publikováno v:
Milbank Q
Policy Points Much concern about generic drug markets has emerged in recent policy debates. Important changes in regulations, the structure of purchasing, and the length of the drug supply chain have affected generic drug markets. Effective price com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4181dd6c5bcf131daded178179091940
https://doi.org/10.1111/1468-0009.12517
https://doi.org/10.1111/1468-0009.12517
Autor:
Mikael Dolsten, Kathy Fernando, Kathrin U. Jansen, Charlotte Moira Norfor Allerton, Michael S. Vincent, Shuang S. Wu
Publikováno v:
Drug Discovery Today. 26:308-314
The pharmaceutical industry has faced declining research and development (R&D) productivity for decades. During the early 2010s, Pfizer saw its R&D productivity drop even more sharply than did its industry peers. As impactful medicines the company ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc4897e1a5c0a012a5c88a19436eab3b
https://doi.org/10.1016/j.drudis.2020.10.019
https://doi.org/10.1016/j.drudis.2020.10.019
Autor:
Miguel Silva, Marco T. Sabatini
Publikováno v:
Pharmaceutical Medicine. 34:271-278
The rise of new product classes such as biologics and complex molecules over the past two decades have brought to light some of the unique market dynamics that such products face. While we have seen and experienced the inception, growth and expansion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d407441c7dfcf9071a2a0033ebbdf7
https://doi.org/10.1007/s40290-020-00348-7
https://doi.org/10.1007/s40290-020-00348-7
Publikováno v:
Pharmaceuticals, Vol 5, Iss 12, Pp 1393-1408 (2012)
Patents for several biologic blockbusters will expire in the next few years. The arrival of biosimilars, the biologic equivalent of chemical generics, will have an impact on the current biopharmaceuticals market. Five core capabilities have been iden
Externí odkaz:
https://doaj.org/article/ac13f8e0f6b94197b84f34669bfa4db8
Autor:
Harish K. Jain
Through the 1984 Drug Price Competition and Patent Term Restoration Act, the Indian Pharmaceutical Industry has thrived in the US market by selling generic products at competitive rates. However, the traditional and conservative model is no longer su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14d34110a4f7df1531053276f54ac42a
https://doi.org/10.9734/bpi/caprd/v3/13587d
https://doi.org/10.9734/bpi/caprd/v3/13587d
Autor:
Marc-André Gagnon
Publikováno v:
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 191(45)
BACKGROUND: Brand discount cards have become a popular way for patients to reduce out-of-pocket spending on drugs; however, controversy exists over their potential to increase insurers’ costs. We estimated the impact of brand discount cards on Cana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceef3d76272b346448a8c6520498427b
https://pubmed.ncbi.nlm.nih.gov/31712357
https://pubmed.ncbi.nlm.nih.gov/31712357
Autor:
Pitko, Vanessa
This case is entitled to discuss the strategic motivation of Bristol-Myers Squibb to conduct the merger with the biotechnology company Celgene by considering the company’s current situation as well as the current economic environment. Besides strat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1437::7b46c6462d9ff53f77e96380955a4930
https://hdl.handle.net/10362/105621
https://hdl.handle.net/10362/105621
Publikováno v:
Journal of Science and Technology Policy Management. 7:258-272
Purpose The paper aims to study how global pharmaceutical companies such as Pfizer have managed the challenges of pharmaceutical patent expiry. Design/methodology/approach A case study method was applied. The best-selling brand drug over the past 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d63a762981a5f794fd589d8ced5d65f
https://doi.org/10.1108/jstpm-12-2015-0040
https://doi.org/10.1108/jstpm-12-2015-0040
Autor:
Takao Fujiwara
Publikováno v:
Global Journal of Flexible Systems Management. 17:417-424
Although Japan has both a globally rare national mandated healthcare program and one of the most extensive life science research capabilities in the world, there is a future risk of their divergence due to Japan’s aging citizenry and the patent cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d3b9143c6530fd38e594e2523302cc7
https://doi.org/10.1007/s40171-016-0129-1
https://doi.org/10.1007/s40171-016-0129-1
Publikováno v:
Journal of Applied Pharmaceutical Science. :206-222
Article history: In the last one decade, due to expiry of patented products as well as their exclusivity period, a drastic decline of branded pharmaceutical products and up streaming of generic drug market has been observed in developed as well as de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f4de98b3d5f64f3f36cbd713b59d186
https://doi.org/10.7324/japs.2016.60430
https://doi.org/10.7324/japs.2016.60430